Yang Jing, Yin Hong-Shan, Cao Ya-Jing, Jiang Zhi-An, Li Yong-Jun, Song Mu-Chun, Wang Yong-Fei, Wang Zhi-Hua, Yang Rong, Jiang Yun-Fa, Sun Jin-Peng, Liu Bo-Yi, Wang Chuan
Department of Physiology, Hebei Medical University, Shijiazhuang, China.
Department of Cardiology, the Third Hospital of Hebei Medical University, Shijiazhuang, China.
Cell Physiol Biochem. 2018;49(2):728-742. doi: 10.1159/000493038. Epub 2018 Aug 30.
BACKGROUND/AIMS: Arctigenin (ATG) has been shown to possess anti-inflammatory, immunemodulatory, anti-viral, anti-microbial, anti-carcinogenic, vasodilatory and anti-platelet aggregation properties. However, the protective role of ATG in prevention of arrhythmias induced by myocardial ischemia/reperfusion is unknown. The aim of this study was to investigate the anti-arrhythmia effect of ATG in an ischemia/reperfusion injured rat heart model and explore the related mechanisms.
Rats were randomly exposed to sham operation, myocardial ischemia/ reperfusion (MI/R) alone, ATG+ MI/R, pretreated with ATG in low (12.5 mg/kg/day), medium (50 mg/kg/day) and high dose (200 mg/kg/day), respectively. Ventricular arrhythmias were assessed. The activity of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and the level of malondialdehyde (MDA) in myocardial tissue were determined by chemical analysis.
Compared to MI/R, rats pretreated with ATG in doses of 50 mg/kg/day and 200 mg/kg/day showed significantly reduced incidence and duration of ventricular fibrillation, ventricular tachycardia and ventricular ectopic beat (VEB), and decreased the arrhythmia score during the 30-min ischemia. Incidence and duration of ventricular tachycardia, infarction size and arrhythmia scores in these groups were significantly decreased during the 120-min reperfusion. No ventricular fibrillation occurred during the period of reperfusion. Rats pretreated with ATG in doses of 50 mg/kg/day and 200 mg/kg/ day markedly enhanced the activities of antioxidant enzymes SOD and GSH-Px, reduced the level of MDA. No differences were observed between the group pretreated with a low dose of ATG and the sham group. Administration of ATG significantly increased the expression of antioxidant stress protein Nrf2, Trx1 and Nox1.
Our data suggested that ATG plays anti-arrhythmia role in ischemia/reperfusion injury, which is probably associated with attenuating oxidative stress by Nrf2 signaling pathway.
背景/目的:牛蒡子苷元(ATG)已被证明具有抗炎、免疫调节、抗病毒、抗菌、抗癌、血管舒张和抗血小板聚集特性。然而,ATG在预防心肌缺血/再灌注诱导的心律失常中的保护作用尚不清楚。本研究旨在探讨ATG在缺血/再灌注损伤大鼠心脏模型中的抗心律失常作用,并探索相关机制。
将大鼠随机分为假手术组、单纯心肌缺血/再灌注(MI/R)组、低剂量(12.5mg/kg/天)、中剂量(50mg/kg/天)和高剂量(200mg/kg/天)ATG预处理+MI/R组。评估室性心律失常。通过化学分析测定心肌组织中超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)的活性以及丙二醛(MDA)的水平。
与MI/R组相比,50mg/kg/天和200mg/kg/天剂量ATG预处理的大鼠在30分钟缺血期间,室颤、室性心动过速和室性早搏(VEB)的发生率和持续时间显著降低,心律失常评分降低。在120分钟再灌注期间,这些组的室性心动过速发生率和持续时间、梗死面积和心律失常评分显著降低。再灌注期间未发生室颤。50mg/kg/天和200mg/kg/天剂量ATG预处理的大鼠显著增强了抗氧化酶SOD和GSH-Px的活性,降低了MDA水平。低剂量ATG预处理组与假手术组之间未观察到差异。给予ATG显著增加了抗氧化应激蛋白Nrf2、Trx1和Nox1的表达。
我们的数据表明,ATG在缺血/再灌注损伤中发挥抗心律失常作用,这可能与通过Nrf2信号通路减轻氧化应激有关。